Latest News and Press Releases
Want to stay updated on the latest news?
-
SAN DIEGO, CA--(Marketwire - January 12, 2009) - Nerveda Inc. and Aegis Therapeutics LLC today announced preclinical results from their joint collaboration aimed at developing non-injectable...
-
SAN DIEGO, CA--(Marketwire - November 12, 2008) - Aegis Therapeutics LLC announced today that preclinical data was presented at the 2008 International Congress of Endocrinology in Rio de Janeiro,...
-
SAN DIEGO, CA--(Marketwire - September 16, 2008) - Aegis Therapeutics LLC announced today that it has been awarded U.S. Patent 7,425,542, titled "Stabilizing alkylglycoside compositions and methods...
-
SAN DIEGO, CA--(Marketwire - September 8, 2008) - Aegis Therapeutics, a drug delivery technology licensing company and leader in transmucosal drug delivery, will present a talk entitled:...
-
SAN DIEGO, CA--(Marketwire - August 21, 2008) - Aegis Therapeutics, a drug delivery technology licensing company and leader in transmucosal drug delivery, will present a talk entitled: "New...
-
Aegis Therapeutics to Present at the "C21 BioVentures Conference" in Monterey California in May 2007
SAN DIEGO, CA -- (MARKET WIRE) -- April 4, 2007 -- Aegis Therapeutics, a drug delivery technology licensing company and leader in transmucosal drug delivery, will present its recently formed Cedar...
-
SAN DIEGO, CA -- (MARKET WIRE) -- April 3, 2007 -- Aegis Therapeutics, a leader in intranasal drug delivery, will present a talk entitled: "High-Efficiency Delivery of Peptides, Proteins, and Other...
-
SAN DIEGO, CA -- (MARKET WIRE) -- November 16, 2006 -- Aegis Therapeutics, a leader in intranasal drug delivery, will present a talk entitled: "High-Efficiency Transmucosal Delivery of Peptide and...
-
SAN DIEGO, CA -- (MARKET WIRE) -- November 15, 2006 -- Aegis Therapeutics, a drug delivery technology company providing exceptionally high and unmatched bioavailability for non-invasive intranasal...